FDA Grants Clearance for RIVANNA's Accuro 3S Needle Guide Kit
RIVANNA, a pioneer in imaging-based medical technologies, has celebrated a major achievement with the U.S. Food and Drug Administration's (FDA) granting of 510(k) clearance for its Accuro 3S Needle Guide Kit. This milestone serves to enhance safety and effectiveness across ultrasound-guided needle placement.
Innovative Design of the Accuro 3S Needle Guide Kit
The Accuro 3S Needle Guide Kit is tailored for use with the cutting-edge Accuro 3S ultrasound imaging system. Boasting an array of single-use, sterile components, it sets a new standard in infection control while streamlining workflow efficiency. A notable feature of the kit is its sterile patient drape, designed with stabilization bands that keep the transducer secure, allowing for hands-free operation during needle insertion. This innovative design enables clinicians to maintain both hands on the needle, affording them essential tactile feedback throughout the procedure.
Ergonomic and Efficient Operations
One distinctive advantage of the Accuro 3S Needle Guide Kit is its ergonomic design. As highlighted by Will Mauldin, PhD, Co-founder and CEO of RIVANNA, the kit's features not only improve efficiency, but also address longstanding ergonomic concerns associated with real-time neuraxial needle placement. The transducer’s stabilization bands significantly enhance the user experience by enabling single-operator workflows.
Commitment to Safety and Performance
RIVANNA is committed to advancing ultrasound-guided needle placement through thoughtful and user-friendly design principles. The performance and safety of the Accuro 3S Needle Guide Kit have been thoroughly validated through comprehensive testing that aligns with stringent FDA requirements. This commitment ensures that healthcare professionals can rely on the kit’s innovative features to deliver accurate and safe patient care.
RIVANNA: A Leader in Medical Technology
Based in Charlottesville, RIVANNA stands at the forefront of medical device innovation. It develops unique imaging-based technologies that aim to elevate the standards of global healthcare. The company focuses on providing comprehensive imaging solutions suitable for both early and late-stage procedures, particularly within the domains of spinal needle interventions and musculoskeletal diagnostics.
Long-Term Vision
RIVANNA continues to lead the charge in medical technology by consistently striving for improvements and breakthroughs aimed at enhancing patient outcomes across various medical fields. Investing in research and development, the company remains dedicated to innovation that aligns with the needs of healthcare professionals and their patients.
Frequently Asked Questions
What is the Accuro 3S Needle Guide Kit?
The Accuro 3S Needle Guide Kit is a sterile set designed to assist clinicians in ultrasound-guided needle placements, enhancing safety and workflow.
What does FDA clearance indicate?
FDA clearance signifies that the device has met stringent safety and efficacy standards, allowing it to be marketed and used in clinical settings.
How does the kit improve clinician workflow?
The kit's design, including hands-free stabilization of the transducer, allows clinicians to operate more efficiently and effectively.
What is RIVANNA's mission?
RIVANNA's mission is to develop innovative medical technologies that transform standards of care in medical imaging and surgical procedures.
Where can I learn more about RIVANNA?
More information about RIVANNA and its offerings can be found on their official website, where they detail their commitment to medical innovation.
